European Psychiatry - Volume 33 - March 2016

337 / 812

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348 S333
2 National Taras Shevchenko University of Kyiv, Educational and
Scientific Centre “Institute of Biology”- Department of Physiology of
Brain and Psychophysiology, Kiev, Ukraine
3 High School 6, Student Government, Chernihiv, Ukraine
4 High School 6, Department of Biology, Chernihiv, Ukraine
∗ Corresponding author.
Media influence on a person qualifies in the context of negative
evaluations of a person’s dependence, especially children, on the
media. The aim of this study was to reveal the influence of TV
news on psycho-emotional state of youth audience, and the extent
to which psychological traits determine their propensity for tele-
vision watching. Forty-two healthy volunteers aged 14–17 years,
the senior pupils of one of high schools in Chernihiv, Ukraine, par-
ticipated in this study. Participants recorded the time they spend
watching TV news and commercials during the month. We used
Temperament and Character Inventory by Cloninger, Cloninger
Tridimensional Personality Questionnaire, Technique of Diagnos-
tics of Ability to Predict by Regush, School Anxiety Test by Philips,
Beck Depression Inventory, Technique of Diagnostics of a Poten-
tial of Communicative Impulsiveness by Losenkov, the Method of
Diagnostics of the Level of Empathic Abilities by Boyko, Maddi Har-
diness Survey, and the Emotional Intelligence Self-Evaluation by
Hall. We found that excessive TV viewing has been linked to the
development of depression among the participants. There was an
inverse correlation between the cognitive-affective and somatic
symptoms of depression and the reward dependence, mediated
by the noradrenergic brain system. The main independent deter-
minants influencing excessive TV viewing were low levels of the
reward dependence and the novelty seeking (which reflects the
activity of dopaminergic brain system). We argue that the propen-
sity for watching TV and depression development can be predicted
by psychological traits, related to the activity of monoaminergic
brain systems.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
Treatment Practice
EW621
Working alliance and its relationship
with treatment outcome
A. Cardoso ∗, P. Aguiar , M. Byrne , M. Xavier
1 Nova Medical School, Mental Health, Lisbon, Portugal
2 Escola Nacional de Saúde Pública, Public Health, Lisbon, Portugal
3 University of Wollongong, Clinical Psychology, Wollongong,
Australia
∗ Corresponding author.
Introduction The therapeutic alliance might be the most impor-
tant part of beginning clinical relationship and may have an
important impact in treatment adherence. In fact, many studies
indicate that the therapeutic alliance is the best predictor of treat-
ment outcome.
Objectives To assess clinical skills and attitudes in mental health
professionals(MHP).
Aims This study explore the impact of clinical skills and
socio-demographic factors related MHP may have on treatment
adherence of patients with mental health disorders (MHD).
Methods In this cross sectional study, we use a convenience
sample of MHP working in the mental health departments of
three general hospitals in Lisbon great area. Data is being col-
lected through individual interviews. We used a optimism scale
(ETOS), Medication Alliance Beliefs Questionnaire (MABQ), and
socio-demographic and clinical questionnaire.
Results A convenience sample composed of sixty-five mental
health clinician working in a variety of settings is being collected.
We don’t found statistically significant differences between the
therapeutic optimismand the socio-demographic and clinical char-
acteristics of MHP. The average values of optimism found in MHP
with additional training in skills training it was higher (t test = 1,64).
The results demonstrate that the most of clinicians (n = 42; agree
64,6%; strongly agree, n = 19; 29,2%) believe that have the capacity
to positively influence outcomes for people with mental disorders.
Conclusion This topic, along with a detailed examination of the
relationship between therapeutic alliance and treatment adher-
ence, will be the subject of future research projects.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW622
Antipsychotic prescribing patterns in
outpatients with severe mental illness
P. Kizilay Cankaya ∗, A. Tiryaki
1 Fatih State Hospital, Psychiatry, Trabzon, Turkey
2 Karadeniz Technical University, Psychiatry, Trabzon, Turkey
∗ Corresponding author.
Introduction Prescribingmore thanone antipsychotic at the same
time is becoming common in the treatment of patients with
severe mental illness (SMI), although most guidelines recommend
monotherapy.
Objectives The aim of this study was to examine the prevalence
of antipsychotic polypharmacy and to compare the practices of
polypharmacy and monotheraphy in terms of the rationale and
compatibility of the treatment.
Methods This study included 235 patients with SMI between 18
and 65 years of age who were followed at KTU Psychiatry Depart-
ment Schizophrenia-Bipolar Disorder outpatient clinic between
January 2007 and December 2014. The sociodemographic and clini-
cal data were evaluated by a chart review formwhichwas prepared
by the researcher and designed according to American Psychiatric
Association treatment algorithm and National Associated Mental
Health Program Directors polypharmacy classification.
Results 138 patients (58.7%) were diagnosed with schizophre-
nia, 75 patients (31.9%) were diagnosed with bipolar disorder and
22 patients (9.4%) were diagnosed with schizoaffective disorder.
62 patients (26.4%) were receiving antipsychotic polypharmacy.
Combinations of two second-generation antipsychotics were most
common. Anticholinergic drug use was significantly more com-
mon in patients on antipsychotic polypharmacy. Reported adverse
events were more common in patients on polypharmacy but did
not reach the level of statistical significance. Patients on antipsy-
chotic polypharmacy were more likely to be diagnosed with
schizophrenia. Polypharmacy patients were also more likely to
receive clozapine and amisulpride whereas monotherapy patients
were more likely to receive olanzapine.
Conclusion Our results confirm previous reports that indicate
patientswith SMI aremost likely to receive antipsychotic polyphar-
macy.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.